South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
Also, the FDA approved Merilog’s 3-milliliter single-patient-use prefilled pen and a 10-milliliter ... rely on daily injections of insulin for treatment of diabetes, having a biosimilar option ...
Quality scores dipped during the COVID-19 pandemic, but are now at or above 2019 levels in areas such as diabetes and asthma management.
After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...
"There’s been a real shortage of these products, particularly since they share production with, for example, the diabetes and weight-loss products." Aspen is adding the ability to make pens and may ...
The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
the diabetes and weight-loss products.” Aspen is adding the ability to make pens and may yet get rights to manufacturer insulin pens, Saad added. South Africa’s regulator has also been called ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results